Atrial natriuretic factor (1-28) (human, porcine) (TFA)
Catalog Number:
MCE-HY-P2281A
| Article Name: |
Atrial natriuretic factor (1-28) (human, porcine) (TFA) |
| Biozol Catalog Number: |
MCE-HY-P2281A |
| Supplier Catalog Number: |
HY-P2281A |
| Alternative Catalog Number: |
MCE-HY-P2281A-1MG,MCE-HY-P2281A-5MG,MCE-HY-P2281A-10MG |
| Manufacturer: |
MedchemExpress |
| Category: |
Proteine/Peptide |
| Alternative Names: |
Atrial natriuretic peptide (1-28) (TFA) |
| Atrial natriuretic factor (1-28) (human, porcine) TFA exhibits blood pressure lowering activity by increasing sodium and urine excretion. Atrial natriuretic factor (1-28) (human, porcine) TFA inhibits the release of pituitary adrenocorticotropic hormone (ACTH) and beta-endorphin through inhibition of pro-opiomelanocortin (POMC) expression. Atrial natriuretic factor (1-28) (human, porcine) TFA increases cGMP levels in RMIC cells with an IC50 of 1.2 nM[1][2][3]. |
| Molecular Weight: |
3080.46 (free base) |
| Purity: |
98.07 |
| Formula: |
C127H205N45O39S3.xC2HF3O2 |
| Target: |
Endogenous Metabolite |
| Application Notes: |
MCE Product type: Peptides |
